Follow
Gregory Kearns
Gregory Kearns
President, Arkansas Children's Research Institute
Verified email at archildrens.org
Title
Cited by
Cited by
Year
Developmental pharmacology—drug disposition, action, and therapy in infants and children
GL Kearns, SM Abdel-Rahman, SW Alander, DL Blowey, JS Leeder, ...
New England Journal of Medicine 349 (12), 1157-1167, 2003
23252003
Handbook of basic pharmacokinetics
WA Ritschel
Drug Intelligence Publications, 1976
9411976
Cytochrome P450 3A
SN de Wildt, GL Kearns, JS Leeder, JN van den Anker
Clinical pharmacokinetics 37 (6), 485-505, 1999
6561999
Glucuronidation in humans
SN de Wildt, GL Kearns, JS Leeder, JN van den Anker
Clinical pharmacokinetics 36 (6), 439-452, 1999
4551999
Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children
C Pihoker, GL Kearns, D French, CY Bowers
The Journal of Clinical Endocrinology & Metabolism 83 (4), 1168-1172, 1998
3541998
Pharmacogenetics in pediatrics: implications for practice
JS Leeder, GL Kearns
Pediatric Clinics of North America 44 (1), 55-77, 1997
2371997
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.
A Gaedigk, RR Gotschall, NS Forbes, SD Simon, GL Kearns, JS Leeder
Pharmacogenetics 9 (6), 669-682, 1999
2301999
Clinical pharmacokinetics in infants and children
GL Kearns, MD Reed
Clinical pharmacokinetics 17 (1), 29-67, 1989
2291989
Acute hepatic failure associated with the use of sodium valproate: report of two fatal cases
FJ Suchy, WF Balistreri, JJ Buchino, JM Sondheimer, SR Bates, ...
New England Journal of Medicine 300 (17), 962-966, 1979
2121979
The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants
GP Heresi, DR Gerstmann, MD Reed, JN van den Anker, JL Blumer, ...
The Pediatric infectious disease journal 25 (12), 1110-1115, 2006
1942006
Ontogeny of drug metabolizing enzymes in the neonate
MJ Blake, L Castro, JS Leeder, GL Kearns
Seminars in Fetal and Neonatal Medicine 10 (2), 123-138, 2005
1942005
Proton pump inhibitors in pediatrics
RM Ward, GL Kearns
Pediatric Drugs 15 (2), 119-131, 2013
1792013
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N‐acetyltransferase‐2, and xanthine oxidase with the “Cooperstown cocktail”
DS Streetman, JF Bleakley, JS Kim, AN Nafziger, JS Leeder, A Gaedigk, ...
Clinical Pharmacology & Therapeutics 68 (4), 375-383, 2000
1762000
Combined phenotypic assessment of cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A, N‐acetyltransferase‐2, and xanthine oxidase activities with the …
S Chainuvati, AN Nafziger, JS Leeder, A Gaedigk, GL Kearns, E Sellers, ...
Clinical pharmacology & therapeutics 74 (5), 437-447, 2003
1722003
Developmental changes in pharmacokinetics and pharmacodynamics
J van den Anker, MD Reed, K Allegaert, GL Kearns
The Journal of Clinical Pharmacology 58, S10-S25, 2018
1592018
Single‐dose pharmacokinetics of ibuprofen and acetaminophen in febrile children
RD Brown, JT Wilson, GL Kearns, VF Eichler, VA Johnson, KM Bertrand
The Journal of Clinical Pharmacology 32 (3), 231-241, 1992
1531992
Pharmacokinetics of an elevated dosage of micafungin in premature neonates
PB Smith, TJ Walsh, W Hope, A Arrieta, A Takada, LL Kovanda, ...
The Pediatric infectious disease journal 28 (5), 412, 2009
1512009
Ontogeny of Dextromethorphan O‐ and N‐demethylation in the First Year of Life
MJ Blake, A Gaedigk, RE Pearce, LR Bomgaars, ML Christensen, ...
Clinical Pharmacology & Therapeutics 81 (4), 510-516, 2007
1482007
Cocaine: clinical pharmacology and toxicology
HC Farrar, GL Kearns
The Journal of pediatrics 115 (5), 665-675, 1989
1461989
Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus
B Van Overmeire, D Touw, PJC Schepens, GL Kearns, JN van den Anker
Clinical Pharmacology & Therapeutics 70 (4), 336-343, 2001
1452001
The system can't perform the operation now. Try again later.
Articles 1–20